1. Home
  2. DVA vs AEG Comparison

DVA vs AEG Comparison

Compare DVA & AEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • AEG
  • Stock Information
  • Founded
  • DVA 1994
  • AEG 1983
  • Country
  • DVA United States
  • AEG Netherlands
  • Employees
  • DVA N/A
  • AEG N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • AEG Life Insurance
  • Sector
  • DVA Health Care
  • AEG Finance
  • Exchange
  • DVA Nasdaq
  • AEG Nasdaq
  • Market Cap
  • DVA 10.9B
  • AEG 9.7B
  • IPO Year
  • DVA 1995
  • AEG N/A
  • Fundamental
  • Price
  • DVA $136.95
  • AEG $6.74
  • Analyst Decision
  • DVA Hold
  • AEG Strong Buy
  • Analyst Count
  • DVA 4
  • AEG 1
  • Target Price
  • DVA $157.00
  • AEG N/A
  • AVG Volume (30 Days)
  • DVA 736.8K
  • AEG 11.3M
  • Earning Date
  • DVA 08-05-2025
  • AEG 07-01-2025
  • Dividend Yield
  • DVA N/A
  • AEG 2.96%
  • EPS Growth
  • DVA 14.90
  • AEG N/A
  • EPS
  • DVA 10.11
  • AEG 0.39
  • Revenue
  • DVA $12,968,524,000.00
  • AEG $13,292,266,284.00
  • Revenue This Year
  • DVA $6.46
  • AEG N/A
  • Revenue Next Year
  • DVA $3.24
  • AEG $2.01
  • P/E Ratio
  • DVA $13.41
  • AEG $16.94
  • Revenue Growth
  • DVA 5.11
  • AEG N/A
  • 52 Week Low
  • DVA $131.76
  • AEG $5.42
  • 52 Week High
  • DVA $179.60
  • AEG $7.32
  • Technical
  • Relative Strength Index (RSI)
  • DVA 44.92
  • AEG 40.85
  • Support Level
  • DVA $134.64
  • AEG $6.67
  • Resistance Level
  • DVA $138.26
  • AEG $7.08
  • Average True Range (ATR)
  • DVA 2.71
  • AEG 0.08
  • MACD
  • DVA 0.14
  • AEG -0.08
  • Stochastic Oscillator
  • DVA 54.56
  • AEG 10.00

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About AEG Aegon Ltd. New York Registry Shares

Aegon is a life insurance and long-term savings company listed in the Netherlands. It listed on the Amsterdam Stock Exchange in the 1980s and now has mature operations in the United States, United Kingdom, and four growth markets of Brazil, China, Portugal, and Spain. Over recent years, Aegon has been moving through an extensive transformation program where management has sought to divest noncore operations and improve the risk profile of the business. Financial assets are the parts of the group that are now being run off. Aegon is looking to cycle out of capital-consumptive and volatile-earnings products and recycle funds into capital-light and more predictable strategic businesses.

Share on Social Networks: